Crystal Structure of a Protein from Vibrio cholerae Reveals Drug-Binding Capabilities
Author Information
Author(s): Deshpande Chandrika N., Harrop Stephen J., Boucher Yan, Hassan Karl A., Leo Rosa Di, Xu Xiaohui, Cui Hong, Savchenko Alexei, Chang Changsoo, Labbate Maurizio, Paulsen Ian T., Stokes H. W., Curmi Paul M. G., Mabbutt Bridget C.
Primary Institution: Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, New South Wales, Australia
Hypothesis
The study investigates the structure and function of an integron gene cassette-associated protein from Vibrio cholerae to understand its role in drug binding and resistance.
Conclusion
The Cass2 protein is capable of binding cationic drug compounds with high affinity and may represent an evolutionary precursor to multi-domain transcription regulators.
Supporting Evidence
- The study reports the 1.8 Å crystal structure of the Cass2 protein.
- Cass2 shows a binding pocket for cationic drugs with submicromolar affinity.
- Genetic analysis indicates Cass2 is part of a larger family of effector-binding proteins.
- Fluorescence assays demonstrate significant binding of Cass2 to various cationic compounds.
Takeaway
Scientists studied a protein from a bacteria that can grab onto certain drugs, which might help the bacteria survive against medicines.
Methodology
The study utilized x-ray crystallography to determine the structure of the Cass2 protein and fluorescence assays to test its binding capabilities.
Limitations
The study does not confirm the natural ligand of Cass2 and its role in drug resistance in vivo remains unclear.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website